ROR2 and ovarian cancer: In this study, we aimed to understand whether inflammatory mediators such as lipopolysaccharide (LPS), lipoteichoic acid (LTA) or recombinant human IL-6 (rhIL-6) can modulate Wnt5A and ROR2 expression in the human ovarian cancer cell line SKOV-3.